$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000139681415000015 Filed on October 27, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$69.32M	$62.21M	$52.05M
YoY Change	-64.93%	19.53%	123.78%
Cost Of Revenue	$19.43M	$15.90M	$20.39M
YoY Change	-74.91%	-22.02%	37.86%
Gross Profit	$49.89M	$46.31M	$31.66M
YoY Change	-58.5%	46.29%	273.84%
Gross Profit Margin	71.97%	74.44%	60.82%
Selling, General & Admin	$37.60M	$35.31M	$28.22M
YoY Change	-64.75%	25.14%	84.18%
% of Gross Profit	75.36%	76.24%	89.13%
Research & Development	$13.20M	$5.893M	$4.425M
YoY Change	-29.53%	33.18%	-25.78%
% of Gross Profit	26.46%	12.72%	13.98%
Depreciation & Amortization	$3.120M	$2.800M	$2.300M
YoY Change	-68.91%	21.74%	187.5%
% of Gross Profit	6.25%	6.05%	7.27%
Operating Expenses	$70.13M	$57.10M	$53.03M
YoY Change	-65.42%	7.68%	47.02%
Operating Profit	-$20.24M	$5.109M	-$985.0K
YoY Change	291.87%	-618.68%	-92.31%
Interest Expense	-$1.700M	$1.905M	$2.037M
YoY Change	-120.54%	-6.48%	7.66%
% of Operating Profit		37.29%
Other Income/Expense, Net	-$100.0K	-$1.742M	-$2.019M
YoY Change	-98.81%	-13.72%	2.49%
Pretax Income	-$2.600M	$3.367M	-$3.004M
YoY Change	-80.8%	-212.08%	-79.68%
Income Tax	-$100.0K	$281.0K	$0.00
% Of Pretax Income		8.35%
Net Earnings	-$2.498M	$3.086M	-$3.004M
YoY Change	-81.79%	-202.73%	-79.68%
Net Earnings / Revenue	-3.6%	4.96%	-5.77%
Basic Earnings Per Share		$0.08	-$0.08
Diluted Earnings Per Share	-$67.93K	$0.08	-$0.08
COMMON SHARES
Basic Shares Outstanding	36.76M shares	36.66M shares	35.94M shares
Diluted Shares Outstanding		41.04M shares	35.94M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$159.0M	$146.4M	$149.7M
YoY Change	1.47%	-2.2%	83.01%
Cash & Equivalents	$54.13M	$30.52M	$17.76M
Short-Term Investments	$102.0M	$115.9M	$132.0M
Other Short-Term Assets	$6.100M	$4.600M	$5.300M
YoY Change	1.67%	-13.21%	17.78%
Inventory	$61.65M	$56.13M	$23.66M
Prepaid Expenses
Receivables	$25.86M	$25.92M	$20.52M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$252.6M	$233.1M	$199.2M
YoY Change	17.89%	16.99%	78.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$90.32M	$86.32M	$56.15M
YoY Change	48.97%	53.74%	22.21%
Goodwill	$30.88M	$28.89M	$22.05M
YoY Change	29.96%	31.02%	131.14%
Intangibles
YoY Change
Long-Term Investments	$13.50M	$17.90M	$24.50M
YoY Change	-44.67%	-26.94%
Other Assets	$406.0K	$2.595M	$2.948M
YoY Change	-84.31%	-11.97%	-17.12%
Total Long-Term Assets	$135.2M	$135.9M	$106.2M
YoY Change	20.87%	28.01%	74.85%
TOTAL ASSETS
Total Short-Term Assets	$252.6M	$233.1M	$199.2M
Total Long-Term Assets	$135.2M	$135.9M	$106.2M
Total Assets	$387.7M	$369.0M	$305.4M
YoY Change	18.91%	20.82%	77.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.739M	$8.471M	$7.747M
YoY Change	29.31%	9.35%	396.92%
Accrued Expenses	$35.38M	$30.30M	$23.38M
YoY Change	24.95%	29.56%	50.15%
Deferred Revenue
YoY Change
Short-Term Debt	$104.0M	$104.9M	$102.1M
YoY Change	0.87%	2.74%	4.29%
Long-Term Debt Due	$118.5M	$0.00	$600.0K
YoY Change	-1.22%	-100.0%	-33.33%
Total Short-Term Liabilities	$149.8M	$145.4M	$135.2M
YoY Change	6.98%	7.53%	15.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$11.47M	$6.125M	$5.235M
YoY Change	112.11%	17.0%	79.84%
Total Long-Term Liabilities	$11.47M	$6.125M	$5.235M
YoY Change	112.11%	17.0%	79.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$149.8M	$145.4M	$135.2M
Total Long-Term Liabilities	$11.47M	$6.125M	$5.235M
Total Liabilities	$169.3M	$160.0M	$150.3M
YoY Change	9.31%	6.42%	21.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$308.3M	-$305.8M	-$315.9M
YoY Change	-0.6%	-3.21%	11.06%
Common Stock	$37.00K	$37.00K	$36.00K
YoY Change	2.78%	2.78%	5.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares	0.000 shares
Shareholders Equity	$218.4M	$209.0M	$155.1M
YoY Change
Total Liabilities & Shareholders Equity	$387.7M	$369.0M	$305.4M
YoY Change	18.91%	20.82%	77.15%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$2.498M	$3.086M	-$3.004M
YoY Change	-81.79%	-202.73%	-79.68%
Depreciation, Depletion And Amortization	$3.120M	$2.800M	$2.300M
YoY Change	-68.91%	21.74%	187.5%
Cash From Operating Activities	$16.06M	$2.820M	$8.980M
YoY Change	13.9%	-68.6%	-191.26%
INVESTING ACTIVITIES
Capital Expenditures	-$8.150M	-$9.610M	-$4.950M
YoY Change	-135.46%	94.14%	5.32%
Acquisitions
YoY Change
Other Investing Activities	$16.38M	$2.760M	-$96.86M
YoY Change	47.17%	-102.85%	-1265.58%
Cash From Investing Activities	$8.230M	-$6.840M	-$101.8M
YoY Change	180.89%	-93.28%	-2919.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.170M	1.830M	2.380M
YoY Change	-20.8%	-23.11%	142.86%
NET CHANGE
Cash From Operating Activities	16.06M	2.820M	8.980M
Cash From Investing Activities	8.230M	-6.840M	-101.8M
Cash From Financing Activities	2.170M	1.830M	2.380M
Net Change In Cash	26.46M	-2.190M	-90.44M
YoY Change	33.84%	-97.58%	1622.67%
FREE CASH FLOW
Cash From Operating Activities	$16.06M	$2.820M	$8.980M
Capital Expenditures	-$8.150M	-$9.610M	-$4.950M
Free Cash Flow	$24.21M	$12.43M	$13.93M
YoY Change	-372.51%	-10.77%	-371.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36757420	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
	pcrx	Adjustmentsto Additional Paidin Capital Issuanceof Common Stock Upon Conversionof Convertible Senior Notes AdjustmentstoAdditionalPaidinCapitalIssuanceofCommonStockUponConversionofConvertibleSeniorNotes	3930000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	365000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	361000	USD
CY2014Q3	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	357000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	930000	USD
CY2015Q3	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	357000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1069000	USD
CY2014Q3	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	107000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	107000	USD
CY2015Q3	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	176000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	629000	USD
CY2014Q3	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6249000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	12210000	USD
CY2015Q3	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6991000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	19926000	USD
CY2014Q3	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	1330000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	4882000	USD
CY2015Q3	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	402000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	1459000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2015Q3	pcrx	Conversion Request Convertible Senior Notes ConversionRequestConvertibleSeniorNotes	1500000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	1466000	USD
CY2015Q3	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	1900000	shares
CY2015Q3	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	77700000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	3930000	USD
CY2015Q3	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	5127000	USD
CY2014Q3	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-3004000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-19518000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1838000	shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	199	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9560000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2034000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5927000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3553000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7070000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8105000	USD
CY2015Q3	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	3000	shares
CY2015Q3	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	3367000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	4726000	USD
CY2015Q3	pcrx	Income Tax Provision IncomeTaxProvision	300000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	400000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	641000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	276000	USD
CY2014Q3	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	1000	shares
CY2014Q4	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	103376000	USD
CY2015Q3	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	104907000	USD
CY2014	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	11720000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	5127000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	0	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1195000	USD
CY2014Q4	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	276000	USD
CY2015Q3	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	0	USD
CY2014Q4	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	276000	USD
CY2015Q3	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	0	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
	pcrx	Stock Issued During Period Convertible Senior Notes Conversion StockIssuedDuringPeriodConvertibleSeniorNotesConversion	44000	shares
	pcrx	Stock Issued During Period Proceeds Followon Public Offering Issues StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues	110407000	USD
	pcrx	Stock Issued During Period Proceeds Followon Public Offering Issues StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues	0	USD
CY2015Q3	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	12900000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6758000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8471000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22366000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25919000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28311000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30295000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20114000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25102000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-80000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-29000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	481334000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	514796000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-4100000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23640000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7686000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17199000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8826000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23640000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3104000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3080000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8467000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7638000	shares
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2454000	shares
CY2014Q4	us-gaap	Assets Assets	326072000	USD
CY2015Q3	us-gaap	Assets Assets	368988000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	214257000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	233100000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	143649000	USD
CY2015Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	133866000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	33000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	93000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	62000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	616000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1660000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12515000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17756000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37520000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30522000	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36150620	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36735981	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36150620	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36735981	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	36000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2965000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19515000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3084000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4405000	USD
CY2014Q4	us-gaap	Convertible Debt ConvertibleDebt	120000000	USD
CY2015Q3	us-gaap	Convertible Debt ConvertibleDebt	118534000	USD
CY2014Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	103100000	USD
CY2015Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	104907000	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	20391000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	58472000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	15901000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	52409000	USD
CY2015Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1900000	shares
CY2015Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days DebtInstrumentConvertibleThresholdConsecutiveTradingDays	P30D
CY2015Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.3
CY2015Q3	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	D
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	16900000	USD
CY2015Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	13627000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1426000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1426000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	9508000	USD
CY2015Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8439000	USD
CY2014Q3	us-gaap	Depreciation Depreciation	2300000	USD
	us-gaap	Depreciation Depreciation	6700000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	2800000	USD
	us-gaap	Depreciation Depreciation	8100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7328000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8356000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.08
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.08
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14597000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14839000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	403000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	161000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-157000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2014Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	23761000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	28888000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3004000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-19518000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3776000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6014000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3004000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19518000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3367000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4726000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-409000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1288000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	281000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1069000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	26869000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2142000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	990000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	696000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	647000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	196000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1509000	USD
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2841000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3256000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	1000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1530000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1698000	shares
CY2014Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	300000	USD
CY2015Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	600000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	2037000	USD
	us-gaap	Interest Expense InterestExpense	6222000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	1905000	USD
	us-gaap	Interest Expense InterestExpense	5842000	USD
	us-gaap	Interest Paid InterestPaid	4873000	USD
	us-gaap	Interest Paid InterestPaid	4224000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11383000	USD
CY2015Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	31170000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	29263000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	56132000	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9263000	USD
CY2015Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16096000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8617000	USD
CY2015Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8866000	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	134000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	237000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	171000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	504000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	154927000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	159975000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	326072000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	368988000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	140010000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6125000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-43000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	145411000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	103100000	USD
CY2015Q3	us-gaap	Long Term Debt LongTermDebt	104907000	USD
CY2014Q4	us-gaap	Long Term Investments LongTermInvestments	24431000	USD
CY2015Q3	us-gaap	Long Term Investments LongTermInvestments	17921000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	5241000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6998000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	116139000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8527000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-122740000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-27486000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	11842000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	11961000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-3004000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-19518000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	3086000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4354000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2019000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6435000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1742000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5542000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	53033000	USD
	us-gaap	Operating Expenses OperatingExpenses	148959000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	57104000	USD
	us-gaap	Operating Expenses OperatingExpenses	169408000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-985000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13083000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	5109000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	10268000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	48977000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	8303000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	8081000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7878000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7743000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	15150000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1822000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2588000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2595000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	39000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	51000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	39000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	51000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5409000	USD
	us-gaap	Royalty Expense RoyaltyExpense	330000	USD
CY2015Q3	us-gaap	Royalty Expense RoyaltyExpense	0	USD
	us-gaap	Royalty Expense RoyaltyExpense	71000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-120000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	24465000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14161000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32146000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	140410000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	125197000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4461000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4611000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	68016000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	134984000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5732000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8798000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	80746000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	111425000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60632000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	86323000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4425000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14844000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5893000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15509000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1509000	USD
CY2015Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2014Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
CY2015Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	1257000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	1626000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-310145000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305791000	USD
CY2014Q3	us-gaap	Revenues Revenues	52048000	USD
	us-gaap	Revenues Revenues	135876000	USD
CY2015Q3	us-gaap	Revenues Revenues	62213000	USD
	us-gaap	Revenues Revenues	179676000	USD
CY2014Q3	us-gaap	Royalty Expense RoyaltyExpense	73000	USD
CY2014Q3	us-gaap	Royalty Revenue RoyaltyRevenue	771000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	61150000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	2249000	USD
CY2015Q3	us-gaap	Royalty Revenue RoyaltyRevenue	706000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	2310000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	50920000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	132697000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	176297000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28217000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	75643000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35310000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	101490000	USD
CY2014Q3	us-gaap	Share Based Compensation ShareBasedCompensation	7686000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	17199000	USD
CY2015Q3	us-gaap	Share Based Compensation ShareBasedCompensation	8826000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23640000	USD
CY2015Q3	us-gaap	Share Price SharePrice	41.10
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	119138000	USD
CY2015Q3	us-gaap	Short Term Investments ShortTermInvestments	115916000	USD
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	19883	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1195000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8798000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	171145000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	209013000	USD
CY2014Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	139000	USD
CY2015Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	312000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2015Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35943000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35039000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41043000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41422000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35943000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35039000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36663000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36460000	shares

Files In Submission

Name	View Source	Status
0001396814-15-000015-index-headers.html	Edgar Link	pending
0001396814-15-000015-index.html	Edgar Link	pending
0001396814-15-000015.txt	Edgar Link	pending
0001396814-15-000015-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pcrx-20150930.xml	Edgar Link	completed
pcrx-20150930.xsd	Edgar Link	pending
pcrx-20150930_cal.xml	Edgar Link	unprocessable
pcrx-20150930_def.xml	Edgar Link	unprocessable
pcrx-20150930_lab.xml	Edgar Link	unprocessable
pcrx-20150930_pre.xml	Edgar Link	unprocessable
pcrx-93015xex311.htm	Edgar Link	pending
pcrx-93015xex312.htm	Edgar Link	pending
pcrx-93015xex321.htm	Edgar Link	pending
pcrx-93015xex322.htm	Edgar Link	pending
pcrx-9302015x10xq.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2015 Q4 Form 10-Q Financial Statement

#000139681415000015 Filed on October 27, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2015 Q4 Form 10-Q Financial Statement

#000139681415000015 Filed on October 27, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx